Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Epigenetic Regulation01:46

Epigenetic Regulation

31.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.4K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.4K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

7.5K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.5K
Inheritance of Chromatin Structures03:17

Inheritance of Chromatin Structures

6.6K
Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
6.6K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

11.9K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.9K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Hypereosinophilic syndrome mimicking gastric malignancy: considerations on the challenging diagnosis-a case report and review of the literature.

Journal of medical case reports·2026
Same author

Histone chaperone-based stratification combined with two-sample Mendelian randomization identifies ADORA2B and SAPCD2 as prognostic biomarkers in esophageal cancer.

Frontiers in oncology·2026
Same author

G6PD deficiency is implicated in Circle of Willis variants in stroke patients and impairs brain vasculature in zebrafish.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2025
Same author

Unmasking the Esophageal Submucosal Enigma.

Digestive diseases and sciences·2025
Same author

A Rare Case of Refractory Duodenal Ulcer With Progressive Aggravation Despite Conventional Treatment.

Journal of gastroenterology and hepatology·2025
Same author

Aspirin Induced Colonic Ulcer in Patients with Acute Coronary Syndrome.

Digestive diseases and sciences·2025

Video Experimental Relacionado

Updated: Sep 10, 2025

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

11.0K

El LncRNA CRAT40 mediado por metilación promueve la progresión del cáncer colorrectal mediante el reclutamiento de

Qing Lu1,2, Xiuhe Lv1,2, Jin Wang1,2

  • 1Department of Gastroenterology and Hepatology, West China Hospital of Sichuan University, Chengdu 610041, Sichuan, China.

International journal of biological sciences
|August 27, 2025
PubMed
Resumen

La progresión del cáncer colorrectal (CRC) es impulsada por el ARN largo no codificante lnc-CRAT40. Este estudio revela que lnc-CRAT40 promueve el crecimiento tumoral y la metástasis, ofreciendo un potencial biomarcador y objetivo terapéutico para el CCR.

Palabras clave:
METTL3 (en inglés)YBX1 (en inglés)Cáncer colorrectalARN largo no codificante

Más Videos Relacionados

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

892
Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

7.0K

Videos de Experimentos Relacionados

Last Updated: Sep 10, 2025

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

11.0K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

892
Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

7.0K

Área de la Ciencia:

  • En el campo de la oncología
  • Biología molecular
  • La genética

Sus antecedentes:

  • El cáncer colorrectal (CRC) es un problema de salud mundial importante con una alta mortalidad.
  • Los ARN largos no codificantes (ARNlnc) juegan un papel importante en el desarrollo y la progresión del cáncer.
  • La identificación de nuevos reguladores moleculares es crucial para mejorar las estrategias de tratamiento de la CCR.

Objetivo del estudio:

  • Para investigar el papel de lnc-CRAT40 en el cáncer colorrectal.
  • Para dilucidar los mecanismos moleculares por los cuales lnc-CRAT40 influye en la progresión de CRC.
  • Evaluar el lnc-CRAT40 como un potencial biomarcador de pronóstico para el CCR.

Principales métodos:

  • PCR cuantitativa en tiempo real para evaluar los niveles de expresión de lnc-CRAT40 en los tejidos CRC.
  • Ensayos funcionales in vitro e in vivo para determinar el impacto de lnc-CRAT40 en la proliferación y metástasis de las células tumorales.
  • La inmunoprecipitación de ARN y las pruebas de Western blot para investigar la interacción entre lnc-CRAT40, METTL3, YBX1 y el promotor de RelA.
  • Análisis de la modificación de la N6-metiladenosina y su efecto en la estabilidad de lnc-CRAT40.

Principales resultados:

  • lnc-CRAT40 fue significativamente regulado al alza en los tejidos CRC y se correlacionó con un mal pronóstico del paciente.
  • La sobreexpresión de lnc-CRAT40 aumentó la proliferación y la metástasis de las células CRC in vitro e in vivo.
  • La modificación de N6-metiladenosina mediada por METTL3 estabilizó el lnc-CRAT40, contribuyendo a su regulación al alza.
  • lnc-CRAT40 interactuó directamente con YBX1, reclutándolo para el promotor de RelA para activar la señalización NF-κB, promoviendo así la progresión de CRC.

Conclusiones:

  • El lnc-CRAT40 es un factor clave en la proliferación y metástasis del cáncer colorrectal.
  • La vía de señalización METTL3-lnc-CRAT40-YBX1-NF-κB representa un nuevo mecanismo en la patogénesis del CRC.
  • lnc-CRAT40 es prometedor como biomarcador pronóstico y un objetivo terapéutico potencial para el cáncer colorrectal.